Outset Medical, Inc. Increase (Decrease) in Accounts Receivable
Outset Medical, Inc. (OM) reported Increase (Decrease) in Accounts Receivable of $1.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- Outset Medical, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $5.04M.
- Outset Medical, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$3.41M, a 332.38% decline year-over-year.
- Outset Medical, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$1.77M, a 192.08% decline year-over-year.
- Outset Medical, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$2.90M, a 2186.33% decline year-over-year.
- Outset Medical, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$3.77M, a 175.32% decline from fiscal 2024.
- Outset Medical, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $5.01M, a 1.61% decline from fiscal 2023.
- Outset Medical, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $5.09M, a 103.27% increase from fiscal 2022.
- Outset Medical, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $2.51M, a 86.90% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $1.63M 10-Q · filed 2026-08-06 | -$141.00K derived: sum of 3 quarters · filed 2026-08-06 | -$3.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$3.41M 10-Q · filed 2026-05-07 | -$5.18M derived: sum of 2 quarters · filed 2026-05-07 | -$8.08M derived: sum of 3 quarters · filed 2026-05-07 | -$8.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$4.67M derived: sum of 2 quarters · filed 2026-02-13 | -$5.24M derived: sum of 3 quarters · filed 2026-08-06 | -$3.77M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$3.47M derived: sum of 2 quarters · filed 2026-08-06 | -$2.01M 10-Q · filed 2025-11-10 | -$87.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$574.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $893.00K 10-Q · filed 2026-08-06 | $2.81M derived: sum of 3 quarters · filed 2026-08-06 | $2.95M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.47M 10-Q · filed 2026-05-07 | $3.39M derived: sum of 2 quarters · filed 2026-05-07 | $3.53M derived: sum of 3 quarters · filed 2026-05-07 | $2.98M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.06M derived: sum of 2 quarters · filed 2026-02-13 | $1.51M derived: sum of 3 quarters · filed 2026-02-13 | $5.01M 10-K · filed 2026-02-13 |
| 2024-09-30 | $139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$405.00K derived: sum of 2 quarters · filed 2025-11-10 | $3.09M 10-Q · filed 2025-11-10 | $622.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | -$544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.95M 10-Q · filed 2025-08-07 | $483.00K derived: sum of 3 quarters · filed 2026-02-13 | -$872.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $3.50M 10-Q · filed 2025-05-08 | $1.03M derived: sum of 2 quarters · filed 2026-02-13 | -$328.00K derived: sum of 3 quarters · filed 2026-02-13 | $2.37M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | -$2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$3.83M derived: sum of 2 quarters · filed 2026-02-13 | -$1.13M derived: sum of 3 quarters · filed 2026-02-13 | $5.09M 10-K · filed 2026-02-13 |
| 2023-09-30 | -$1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $1.34M derived: sum of 2 quarters · filed 2024-11-07 | $7.56M 10-Q · filed 2024-11-07 | $13.15M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $8.92M 10-Q · filed 2024-08-08 | $14.50M derived: sum of 3 quarters · filed 2025-02-28 | $12.39M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $6.22M 10-Q · filed 2024-05-09 | $11.81M derived: sum of 2 quarters · filed 2025-02-28 | $9.69M derived: sum of 3 quarters · filed 2025-02-28 | $7.43M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $5.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $3.47M derived: sum of 2 quarters · filed 2025-02-28 | $1.21M derived: sum of 3 quarters · filed 2025-02-28 | $2.51M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$4.38M derived: sum of 2 quarters · filed 2023-11-08 | -$3.08M 10-Q · filed 2023-11-08 | $3.22M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | -$2.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$964.00K 10-Q · filed 2023-08-03 | $5.33M derived: sum of 3 quarters · filed 2024-02-21 | $8.23M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $1.30M 10-Q · filed 2023-05-04 | $7.60M derived: sum of 2 quarters · filed 2024-02-21 | $10.49M derived: sum of 3 quarters · filed 2024-02-21 | $14.79M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $9.19M derived: sum of 2 quarters · filed 2024-02-21 | $13.49M derived: sum of 3 quarters · filed 2024-02-21 | $19.14M 10-K · filed 2024-02-21 |
| 2021-09-30 | $2.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $7.19M derived: sum of 2 quarters · filed 2022-11-09 | $12.84M 10-Q · filed 2022-11-09 | $12.21M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $9.95M 10-Q · filed 2022-08-02 | $9.31M derived: sum of 3 quarters · filed 2023-02-13 | $9.11M derived: sum of 4 quarters · filed 2023-02-13 |
| 2021-03-31 | $5.65M 10-Q · filed 2022-05-05 | $5.01M derived: sum of 2 quarters · filed 2023-02-13 | $4.81M derived: sum of 3 quarters · filed 2023-02-13 | $5.16M derived: sum of 4 quarters · filed 2023-02-13 |
| 2020-12-31 | -$631.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | -$836.00K derived: sum of 2 quarters · filed 2023-02-13 | -$489.00K derived: sum of 3 quarters · filed 2023-02-13 | $2.57M 10-K · filed 2023-02-13 |
| 2020-09-30 | -$205.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $142.00K derived: sum of 2 quarters · filed 2021-11-04 | $3.20M 10-Q · filed 2021-11-04 | $2.79M derived: sum of 4 quarters · filed 2022-02-23 |
| 2020-06-30 | $347.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $3.40M 10-Q · filed 2021-08-06 | $2.99M derived: sum of 3 quarters · filed 2022-02-23 | |
| 2020-03-31 | $3.06M 10-Q · filed 2021-05-06 | $2.64M derived: sum of 2 quarters · filed 2022-02-23 | ||
| 2019-12-31 | -$412.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $2.89M 10-K · filed 2022-02-23 | ||
| 2019-09-30 | $3.30M 10-Q · filed 2020-11-12 | |||
| 2018-12-31 | $552.00K 10-K · filed 2021-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |